MHRA confirms people should continue to receive COVID-19 vaccine AstraZeneca

Following rigorous scientific review of all available data, MHRA said available evidence does not suggest venous thromboembolism is caused by COVID-19 Vaccine AstraZeneca and benefits of the vaccines against COVID-19 continue to outweigh any risks.

SPS commentary:

A further, detailed review into five UK reports of sinus vein thrombosis occurring together with thrombocytopenia is ongoing. This has been reported in less than 1 in a million people vaccinated so far in the UK, and can also occur naturally–a causal association with the vaccine has not been established.

Medicines and Healthcare products Regulatory Agency